Tech Company Financing Transactions

Magnolia Neurosciences Funding Round

Magnolia Neurosciences secured a $31 million Series A funding round on 8/14/2018. Investors included 180 Degree Capital, AbbVie Biotech Ventures and Alexandria Venture Investments.

Transaction Overview

Company Information

Company Status
Private & Independent
Mailing Address
430 E 29th St. 840
New York, NY 10016
Email Address
Neurodegenerative diseases and neuronal injuries continue to be an area rife with substantial unmet medical need. Targeting the underlying mechanisms of these diseases is an area of active research for effective therapeutic interventions, but extensive preclinical and clinical efforts have unfortunately resulted in limited success.
Magnolia Neurosciences LinkedIn Company Profile
Social Media
Magnolia Neurosciences Company Twitter Account
Company News
Magnolia Neurosciences News
Magnolia Neurosciences on Facebook
Magnolia Neurosciences on YouTube

Management Team

Email & Social
Chief Executive Officer
Thong Le
  Thong Le LinkedIn Profile  Thong Le Twitter Account  Thong Le News  Thong Le on Facebook



Browse more venture capital transactions:

Prev: 8/14/2018: SKUPOS venture capital transaction
Next: 8/15/2018: Axoni venture capital transaction


Share this article


About Database of VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary